INVICTA Genetic Laboratory is pleased to invite you to visit our stand during the 33st Congress of the European Society of Human Reproduction and Embryology (ESHRE) in Geneva, Switzerland. The ESHRE Congress is being held from July 2 until July 5 at the Geneva’s Exhibition and Congress Centre „Palexpo”.
ESHRE once again invites distinguished international faculty to discuss the latest information, controversy and designation of future directions for science, diagnosis and reproductive medicine.
INVICTA Genetic Laboratory will present latest achievements in the field of PGD Preimplantation Diagnosis using innovative technology of Next Generation Sequencing (NGS) at Booth F01.
The first in the world PGS NGS 360oTM diagnosis (preimplantation genetic diagnosis based on next-generation sequencing platform), developed and introduced into clinical practice by INVICTA uses the most up-to-date techniques of human genome sequencing for testing embryos, providing new diagnostic possibilities.
We hope to see you at INVICTA stand during ESHRE 2017 in Geneva!